Expression patterns of PIK3CA and PTEN in cancer and type 2 diabetes mellitus

Donovan Ariel Rivero1, Jacqueline Lisset Tomsich2, Paula Agustina Benegas1

  • 1Laboratorio de Biotecnología Molecular, Instituto de Biotecnología Misiones, Facultad de Ciencias Exactas, Químicas y Naturales (FCEQyN), Universidad Nacional de Misiones (UNaM), "Dra. María Ebe Reca", Ruta 12, km 7.5, C.P.: 3300, Miguel Lanús, Posadas, Misiones, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina (CONICET), Buenos Aires, Argentina.

Gene
|September 13, 2025
PubMed

Insights

This study found altered PIK3CA and PTEN gene expression in patients with type 2 diabetes mellitus (T2DM) and cancer. These gene expression changes may indicate systemic pathway alterations, suggesting potential roles in disease progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Type 2 diabetes mellitus (T2DM) and cancer share common metabolic pathways, notably the PI3K/PTEN/AKT signaling cascade.
  • This pathway is crucial for regulating glucose metabolism and cell proliferation, linking T2DM and cancer development.

Purpose of the Study:

  • To investigate the expression levels of PIK3CA and PTEN genes in individuals with cancer and T2DM.
  • To explore the potential role of these genes in cancer progression within the context of diabetes.

Main Methods:

  • Gene expression analysis using real-time PCR in 115 participants across four groups: healthy controls, T2DM patients, cancer patients, and patients with both conditions.
  • Assessment of biochemical parameters and statistical analysis using Kruskal-Wallis and Spearman correlation tests.

Main Results:

  • PIK3CA gene expression was significantly higher in cancer patients (77% overexpression) compared to other groups.
  • PTEN gene expression was significantly lower in T2DM and cancer with T2DM groups compared to cancer-only patients.
  • No significant differences in PIK3CA expression were found across different cancer types.

Conclusions:

  • PIK3CA and PTEN gene expression patterns suggest potential as peripheral indicators of PI3K/PTEN pathway alterations in cancer and T2DM.
  • Further research, including tissue validation and biomarker assessment, is warranted to confirm these findings and their clinical implications.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
461
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K